| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.
|
J Clin Endocrinol Metab
|
2003
|
1.93
|
|
2
|
Clinical and epidemiological description of aortic dissection in Turner's syndrome.
|
Cardiol Young
|
2006
|
1.86
|
|
3
|
Weight loss increases circulating levels of ghrelin in human obesity.
|
Clin Endocrinol (Oxf)
|
2002
|
1.76
|
|
4
|
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
|
J Clin Endocrinol Metab
|
2013
|
1.74
|
|
5
|
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.
|
Growth Horm IGF Res
|
2008
|
1.72
|
|
6
|
Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.
|
Diabetes
|
2005
|
1.44
|
|
7
|
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients.
|
Nephrol Dial Transplant
|
2011
|
1.44
|
|
8
|
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
|
Am J Physiol Endocrinol Metab
|
2003
|
1.30
|
|
9
|
Elevated levels of mannan-binding lectin in patients with type 1 diabetes.
|
J Clin Endocrinol Metab
|
2003
|
1.18
|
|
10
|
Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome.
|
J Hypertens
|
2006
|
1.13
|
|
11
|
Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.08
|
|
12
|
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatment.
|
Clin Epidemiol
|
2012
|
0.99
|
|
13
|
Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure.
|
J Clin Endocrinol Metab
|
2007
|
0.98
|
|
14
|
Growth hormone replacement therapy for adults: into the new millennium.
|
Growth Horm IGF Res
|
2002
|
0.97
|
|
15
|
Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.
|
Pituitary
|
2007
|
0.94
|
|
16
|
Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules.
|
Eur J Endocrinol
|
2006
|
0.94
|
|
17
|
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
|
Obes Res
|
2002
|
0.93
|
|
18
|
The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome.
|
Eur J Endocrinol
|
2004
|
0.92
|
|
19
|
Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients.
|
Am J Physiol Endocrinol Metab
|
2003
|
0.92
|
|
20
|
Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.
|
Drugs
|
2012
|
0.91
|
|
21
|
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
|
J Clin Endocrinol Metab
|
2003
|
0.91
|
|
22
|
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
|
J Clin Endocrinol Metab
|
2013
|
0.90
|
|
23
|
IDegAsp: a novel soluble insulin analogs combination.
|
Expert Opin Biol Ther
|
2012
|
0.89
|
|
24
|
Mortality and GH deficiency: a nationwide study.
|
Eur J Endocrinol
|
2007
|
0.89
|
|
25
|
Limitations to subcutaneous insulin administration in type 1 diabetes.
|
Diabetes Obes Metab
|
2003
|
0.89
|
|
26
|
Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone.
|
J Clin Endocrinol Metab
|
2002
|
0.88
|
|
27
|
Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop.
|
Diabetes Res Clin Pract
|
2012
|
0.88
|
|
28
|
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study.
|
J Clin Endocrinol Metab
|
2010
|
0.88
|
|
29
|
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
|
Growth Horm IGF Res
|
2010
|
0.88
|
|
30
|
Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
|
Pediatrics
|
2002
|
0.87
|
|
31
|
Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism.
|
J Clin Endocrinol Metab
|
2013
|
0.86
|
|
32
|
Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging.
|
Cardiol Young
|
2010
|
0.86
|
|
33
|
A multistep algorithm for processing and calibration of microdialysis continuous glucose monitoring data.
|
Diabetes Technol Ther
|
2013
|
0.86
|
|
34
|
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
|
Endocrine
|
2011
|
0.86
|
|
35
|
Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.
|
J Clin Endocrinol Metab
|
2010
|
0.85
|
|
36
|
Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study.
|
J Clin Endocrinol Metab
|
2002
|
0.85
|
|
37
|
Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.85
|
|
38
|
Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study.
|
Cardiovasc Diabetol
|
2013
|
0.84
|
|
39
|
Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes.
|
Diabetes Technol Ther
|
2012
|
0.84
|
|
40
|
Mortality and socioeconomic status in adults with childhood onset GH deficiency (GHD) is highly dependent on the primary cause of GHD.
|
Eur J Endocrinol
|
2012
|
0.84
|
|
41
|
Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
|
Eur J Endocrinol
|
2004
|
0.84
|
|
42
|
Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
|
Clin Endocrinol (Oxf)
|
2005
|
0.83
|
|
43
|
Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial.
|
Eur J Endocrinol
|
2007
|
0.83
|
|
44
|
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
|
Growth Horm IGF Res
|
2011
|
0.83
|
|
45
|
Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
|
J Clin Endocrinol Metab
|
2005
|
0.82
|
|
46
|
Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.
|
Endocr Connect
|
2014
|
0.82
|
|
47
|
Changes in glycaemic control are related to the systolic function in type 1 diabetes mellitus.
|
Scand Cardiovasc J
|
2007
|
0.82
|
|
48
|
Morbidity and GH deficiency: a nationwide study.
|
Eur J Endocrinol
|
2008
|
0.81
|
|
49
|
The management of adult growth hormone deficiency syndrome.
|
Expert Opin Pharmacother
|
2008
|
0.81
|
|
50
|
Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c.
|
J Diabetes Sci Technol
|
2007
|
0.81
|
|
51
|
Glycemia, lipidemia and systolic left ventricular function evaluated by myocardial strain rate: a tissue Doppler echocardiographic study.
|
Ultrasound Med Biol
|
2007
|
0.81
|
|
52
|
Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.
|
Growth Horm IGF Res
|
2009
|
0.81
|
|
53
|
Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults.
|
Horm Res
|
2005
|
0.81
|
|
54
|
The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
|
Growth Horm IGF Res
|
2006
|
0.80
|
|
55
|
The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
|
J Am Geriatr Soc
|
2004
|
0.80
|
|
56
|
Estradiol acutely inhibits whole body lipid oxidation and attenuates lipolysis in subcutaneous adipose tissue: a randomized, placebo-controlled study in postmenopausal women.
|
Eur J Endocrinol
|
2012
|
0.79
|
|
57
|
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
|
Clin Endocrinol (Oxf)
|
2007
|
0.79
|
|
58
|
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
|
Eur J Endocrinol
|
2006
|
0.79
|
|
59
|
Quantitative liver functions in Turner syndrome with and without hormone replacement therapy.
|
Eur J Endocrinol
|
2007
|
0.79
|
|
60
|
A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study.
|
Diabetes Technol Ther
|
2012
|
0.78
|
|
61
|
The effect of growth hormone on the insulin-like growth factor system during fasting.
|
J Clin Endocrinol Metab
|
2003
|
0.78
|
|
62
|
Evaluation of growth hormone stimulation tests in cured acromegalic patients.
|
Growth Horm IGF Res
|
2003
|
0.78
|
|
63
|
Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
|
Growth Horm IGF Res
|
2002
|
0.78
|
|
64
|
Biochemical definitions of disease activity in acromegaly.
|
Growth Horm IGF Res
|
2003
|
0.78
|
|
65
|
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2008
|
0.78
|
|
66
|
Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey.
|
Clin Endocrinol (Oxf)
|
2003
|
0.78
|
|
67
|
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism.
|
Eur J Endocrinol
|
2005
|
0.78
|
|
68
|
Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse.
|
Growth Horm IGF Res
|
2011
|
0.78
|
|
69
|
The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
|
J Clin Endocrinol Metab
|
2002
|
0.77
|
|
70
|
Vitamin C treatment reduces transcapillary escape rate of albumin in type 1 diabetes.
|
Eur J Intern Med
|
2004
|
0.77
|
|
71
|
Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
|
Eur J Endocrinol
|
2005
|
0.77
|
|
72
|
Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age.
|
J Clin Endocrinol Metab
|
2002
|
0.77
|
|
73
|
Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.
|
J Appl Physiol (1985)
|
2003
|
0.77
|
|
74
|
Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement.
|
Indian J Endocrinol Metab
|
2011
|
0.77
|
|
75
|
Interindividual and intraindividual variations in postprandial glycemia peak time complicate precise recommendations for self-monitoring of glucose in persons with type 1 diabetes mellitus.
|
J Diabetes Sci Technol
|
2012
|
0.77
|
|
76
|
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.
|
BMC Endocr Disord
|
2012
|
0.76
|
|
77
|
Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohort.
|
BMC Endocr Disord
|
2014
|
0.76
|
|
78
|
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia.
|
Diabetes Technol Ther
|
2014
|
0.76
|
|
79
|
Protein metabolism in Turner syndrome and the impact of hormone replacement therapy.
|
Clin Endocrinol (Oxf)
|
2007
|
0.76
|
|
80
|
Hypertension and Diabetic Nephropathy.
|
Endocr Dev
|
2016
|
0.76
|
|
81
|
Serum insulin aspart concentrations following high-dose insulin aspart administered directly into the duodenum of healthy subjects: an open-labeled, single-blinded, and uncontrolled exploratory trial.
|
J Diabetes Sci Technol
|
2009
|
0.75
|
|
82
|
Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes.
|
BMC Endocr Disord
|
2014
|
0.75
|
|
83
|
A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.
|
Basic Clin Pharmacol Toxicol
|
2009
|
0.75
|
|
84
|
[Guidelines on diagnosis of type 2 diabetes. Investigation, diagnosis and glucose measurement].
|
Ugeskr Laeger
|
2003
|
0.75
|
|
85
|
[Sexual dysfunction in diabetes mellitus].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
86
|
[Insulin pump treatment in Denmark].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
87
|
[In Process Citation].
|
Ugeskr Laeger
|
2014
|
0.75
|
|
88
|
Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients.
|
Growth Horm IGF Res
|
2007
|
0.75
|
|
89
|
Long-acting growth hormone.
|
Paediatr Drugs
|
2013
|
0.75
|
|
90
|
Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients.
|
Diabetes Technol Ther
|
2015
|
0.75
|
|
91
|
Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
|
Diabetes Metab Res Rev
|
2014
|
0.75
|
|
92
|
Impact of GHBP interference on estimates of GH and GH pharmacokinetics.
|
Clin Endocrinol (Oxf)
|
2002
|
0.75
|
|
93
|
Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days.
|
Nephrol Dial Transplant
|
2012
|
0.75
|
|
94
|
Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty.
|
Hum Reprod
|
2002
|
0.75
|
|
95
|
Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
|
J Pediatr Endocrinol Metab
|
2002
|
0.75
|